Related references
Note: Only part of the references are listed.Population-specific common SNPs reflect demographic histories and highlight regions of genomic plasticity with functional relevance
Ananyo Choudhury et al.
BMC GENOMICS (2014)
RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
Martin J. Larsen et al.
BMC MEDICAL GENOMICS (2014)
Long-term impact of the 70-gene signature on breast cancer outcome
C. A. Drukker et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
ER and PR Immunohistochemistry and HER2 FISH versus Oncotype DX: Implications for Breast Cancer Treatment
MiHee M. Park et al.
BREAST JOURNAL (2014)
HER2 testing: Current status and future directions
Edith A. Perez et al.
CANCER TREATMENT REVIEWS (2014)
Clinical Application of Whole-Genome Sequencing Proceed With Care
William Gregory Feero
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
Yufei Wang et al.
NATURE GENETICS (2014)
Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application
Darnielle Delport et al.
METABOLIC BRAIN DISEASE (2014)
The challenge of implementing genetic tests with clinical utility while avoiding unsound applications
Martina C. Cornel et al.
JOURNAL OF COMMUNITY GENETICS (2014)
Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
Davy Vancampfort et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement
H. A. Azim et al.
ANNALS OF ONCOLOGY (2013)
Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort
Rachel Greenup et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
Stefan Glueck et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Prioritising risk pathways of complex human diseases based on functional profiling
Yan Li et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Self-guided management of exome and whole-genome sequencing results: changing the results return model
Joon-Ho Yu et al.
GENETICS IN MEDICINE (2013)
The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing
Joseph F. Boland et al.
HUMAN GENETICS (2013)
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
C. A. Drukker et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters
Hiltrud Brauch et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review
Inez Wens et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
leAssociation of nephrolithiasis with metabolic syndrome and its components
Yang-Ju Kim et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Measuring the Global Burden of Disease
Christopher J. L. Murray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles
Francisco Javier Gracia-Aznarez et al.
PLOS ONE (2013)
Complete Genome Phasing of Family Quartet by Combination of Genetic, Physical and Population-Based Phasing Analysis
Julien Lajugie et al.
PLOS ONE (2013)
Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
Martin J. Larsen et al.
PLOS ONE (2013)
Pathology-supported genetic testing directed at shared disease pathways for optimized health in later life
Maritha J. Kotze et al.
PERSONALIZED MEDICINE (2013)
Rare-variant genome-wide association studies: a new frontier in genetic analysis of complex traits
Michael J. Wagner
PHARMACOGENOMICS (2013)
High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing
Dianne I. Lou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Whole genome sequencing in support of wellness and health maintenance
Chirag J. Patel et al.
GENOME MEDICINE (2013)
Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing
Jason O'Rawe et al.
GENOME MEDICINE (2013)
Systems Biology and P4 Medicine: Past, Present, and Future
Leroy Hood
RAMBAM MAIMONIDES MEDICAL JOURNAL (2013)
APOE Genotype in the Diagnosis of Alzheimer's Disease in Patients With Cognitive Impairment
Xiaoyan Sun et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2012)
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
Kim De Leeneer et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer
Aditya Bardia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metabolic syndrome as a risk factor for neurological disorders
Akhlaq A. Farooqui et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Bidirectional Association Between Depression and Metabolic Syndrome A systematic review and meta-analysis of epidemiological studies
An Pan et al.
DIABETES CARE (2012)
Potential biomarkers in psychiatry: focus on the cholesterol system
Alisa G. Woods et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer
Shaik Mohammad Naushad et al.
MOLECULAR CARCINOGENESIS (2012)
Rare and common variants: twenty arguments
Greg Gibson
NATURE REVIEWS GENETICS (2012)
Metabolic syndrome meets osteoarthritis
Qi Zhuo et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application
Nicole van der Merwe et al.
METABOLIC BRAIN DISEASE (2012)
Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease
Maritha J. Kotze et al.
METABOLIC BRAIN DISEASE (2012)
Challenges in the Development and Reimbursement of Personalized Medicine-Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
Eric Faulkner et al.
VALUE IN HEALTH (2012)
Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress
Gholson J. Lyon et al.
GENOME MEDICINE (2012)
Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
Andrew A. Davis et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Metabolic syndrome and the risk of breast cancer in postmenopausal women
V. Rosato et al.
ANNALS OF ONCOLOGY (2011)
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk
Amanda I. Phipps et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Inflated type I error rates when using aggregation methods to analyze rare variants in the 1000 Genomes Project exon sequencing data in unrelated individuals: summary results from Group 7 at Genetic Analysis Workshop 17
Nathan Tintle et al.
GENETIC EPIDEMIOLOGY (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
High False- Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study
David J. Dabbs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy
Rui Baptista et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Cancer genomics: from discovery science to personalized medicine
Lynda Chin et al.
NATURE MEDICINE (2011)
Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
Dagmar E. Ehrnhoefer et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence
Frederick E. Dewey et al.
PLOS GENETICS (2011)
Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia
Daniel Zambon et al.
AMERICAN JOURNAL OF MEDICINE (2010)
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
Marieke E. Straver et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
Michael Knauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The Association between Conventional Antidepressants and the Metabolic Syndrome A Review of the Evidence and Clinical Implications
Roger S. McIntyre et al.
CNS DRUGS (2010)
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Lisa J. Moran et al.
HUMAN REPRODUCTION UPDATE (2010)
Iron Status in Children With Recurrent Episodes of Tumefactive Cerebral Demyelination
Ronald van Toorn et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Clinical assessment incorporating a personal genome
Euan A. Ashley et al.
LANCET (2010)
Statistical analysis strategies for association studies involving rare variants
Vikas Bansal et al.
NATURE REVIEWS GENETICS (2010)
Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: A descriptive analysis
F. C. Kruger et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2010)
The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women
Kristine Yaffe et al.
ARCHIVES OF NEUROLOGY (2009)
Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity
Parviz Ghadirian et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD Frequency and Associated Consequences for Systemic Inflammation and Physical Inactivity
Henrik Watz et al.
CHEST (2009)
Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor-Positive Invasive Breast Cancer
Christopher I. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels
John C. Chambers et al.
NATURE GENETICS (2009)
Obstructive Sleep Apnea, Inflammation, and the Metabolic Syndrome
Andrew D. Calvin et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
A Pathway-Based View of Human Diseases and Disease Relationships
Yong Li et al.
PLOS ONE (2009)
Impaired tamoxifen metabolism reduces survival in familial breast cancer patients
William G. Newman et al.
CLINICAL CANCER RESEARCH (2008)
Hyperuricemia, gout and the metabolic syndrome
Juan Garcia Puig et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Pharmacogenomics and therapeutic prospects in dementia
Ramon Cacabelos
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2008)
The Evidence Dilemma In Genomic Medicine
Muin J. Khoury et al.
HEALTH AFFAIRS (2008)
Genome-based prediction of common diseases: advances and prospects
A. Cecile J. W. Janssens et al.
HUMAN MOLECULAR GENETICS (2008)
Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study
Miia Kivipelto et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
The impact of genetics and genomics on public health
Angela Brand et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks
Anna Jakubowska et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
CYP2D6*4 polymorphism is associated with statin-induced muscle effects
Tony N. Frudakis et al.
PHARMACOGENETICS AND GENOMICS (2007)
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers
C. Pepe et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins
Kim D. Pruitt et al.
NUCLEIC ACIDS RESEARCH (2007)
Redefining heart failure: The utility of genomics
Mark P. Donahue et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Basal-like breast cancer and the BRCA1 phenotype
N. C. Turner et al.
ONCOGENE (2006)
Analysis of viral and genetic factors in South African patients with multiple sclerosis
J. Nico P. de Villiers et al.
METABOLIC BRAIN DISEASE (2006)
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
R Shiri-Sverdlov et al.
JOURNAL OF HEPATOLOGY (2006)
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer
Valgerdur Birgisdottir et al.
BREAST CANCER RESEARCH (2006)
High proportions of erectile dysfunction in men with the metabolic syndrome
K Esposito et al.
DIABETES CARE (2005)
The role of molecular genetic testing in modern breast health management
M. J. Kotze et al.
SOUTH AFRICAN FAMILY PRACTICE (2005)
BRCA1 mutations in South African breast and/or ovarian cancer families:: Evidence of a novel founder mutation in Afrikaner families
MD Reeves et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis
M Koruk et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Breast and ovarian cancer
R Wooster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Analysis of the NRAMP1 gene implicated in iron transport: Association with multiple sclerosis and age effects
MJ Kotze et al.
BLOOD CELLS MOLECULES AND DISEASES (2001)
Share Paper
